Oregon’s cannabis sales trends reflect a significant relative decline in demand for flower and pre-rolls, whereas concentrates/extracts have seen strong growth. From December 2016 to December […]
By J.J. McCoy, Senior Managing Editor for New Frontier Data As the cannabis industry makes its first, long-anticipated forays into completely open Pacific Coast legalized markets, […]
Since 2011, more than 7.5 million adults have joined the ranks of now 22.4 million regular cannabis users. New Frontier Data’s research suggests that the increase […]
By Andrew Lines, MAI, Principal Valuations within the growing cannabis industry don’t always seem to be consistent with operator or investor expectations; this can be due […]
The Rohrabacher-Blumenauer Amendment works to protect medical cannabis programs in 29 states and the District of Columbia. The states most affected by a non-renewal of this […]
By J.J. McCoy, Senior Managing Editor for New Frontier Data Newly published findings from the World Health Organization (WHO) about the medicinal benefits of cannabidiol (CBD) […]
Attorney General Jeff Sessions’ Jan. 4 announcement rescinding the Cole Memo sparked a steep but short-lived selloff of U.S. cannabis stocks. By January 11th, stocks had […]